首页> 外文期刊>World Journal of Gastroenterology >Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.
【24h】

Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.

机译:益生菌和乳果糖治疗大鼠最小型肝性脑病的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To compare the efficacy of probiotic preparation Golden Bifid and lactulose on rat experimental model of minimal hepatic encephalopathy (MHE) induced by thioactamide (TAA). METHODS: MHE was induced by intraperitoneal injection of TAA (200 mg/kg) every 24 h for two consecutive days. Thirty-six male MHE models were then randomly divided into 3 groups: TAA group (n = 12) received tap water ad libitum only; lactulose group (n = 12) and probiotics group (n = 12) were gavaged, respectively with 8 mL/kg of lactulose and 1.5 g/kg of probiotic preparation Golden Bifid (highly concentrated combination of probiotic) dissolved in 2 mL of normal saline, once a day for 8 d (from the 5(th) d before the experiment to the 3(rd) d of the experiment). The latency of brainstem auditory evoked potentials (BAEP) I was used as an objective index of MHE. The incidence of MHE, the level of serum endotoxin, ammonia, liver function and histological grade of hepatic injury of rats were examined individually. RESULTS: There were no overt HE and rat deaths in 3 groups. The incidence of MHE, the levels of blood ammonia and endotoxin in TAA group, which were 83.3% (10/12), 168.33+/-15.44 mg/dL and 0.36+/-0.04 EU/mL, respectively, were significantly higher than those in lactulose group, which were 33.3% (4/12), 110.25+/-7.39 mg/dL and 0.19+/-0.02 EU/mL, and probiotics group, which were 33.3% (4/12), 108.58+/-10.24 mg/dL and 0.13+/-0.03 EU/mL respectively (P<0.001). It showed that either probiotics or lactulose could significantly lower the level of hyperammonemia and hyper-endotoxemia, lighten centrolobular necrotic areas as well as inflammatory reaction in the liver of rats, normalize the latency of BAEP, and decrease the incidence of MHE. However, no significant differences were observed between these two groups (P>0.05). CONCLUSION: Probiotic compound Golden Bifid is at least as useful as lactulose for the prevention and treatment of MHE. Probiotic therapy may be a safe, natural, well-tolerated therapy appropriate for the long-term treatment of MHE.
机译:目的:比较益生菌制剂Golden Bifid和乳果糖对硫代酰胺(TAA)诱发的最小肝性脑病(MHE)大鼠实验模型的功效。方法:连续24天每隔24小时腹腔注射TAA(200 mg / kg)诱导MHE。然后将36个男性MHE模型随机分为3组:TAA组(n = 12)仅随意接受自来水; TAA组(n = 12)只接受自来水。分别将乳果糖组(n = 12)和益生菌组(n = 12)分别溶于8 mL / kg的乳果糖和1.5 g / kg的益生菌制剂Golden Bifid(高浓度的益生菌组合)溶于2 mL生理盐水中,每天一次,持续8天(从实验前的第5天到实验的第3天)。脑干听觉诱发电位潜伏期(BAEP)I被用作MHE的客观指标。分别检查大鼠的MHE的发生率,血清内毒素,氨水平,肝功能和肝损伤的组织学等级。结果:3组均没有明显的HE和大鼠死亡。 TAA组的MHE发生率,血氨和内毒素水平分别为83.3%(10/12),168.33 +/- 15.44 mg / dL和0.36 +/- 0.04 EU / mL,明显高于乳果糖组为33.3%(4/12),110.25 +/- 7.39 mg / dL和0.19 +/- 0.02 EU / mL,益生菌组为33.3%(4/12),108.58 + /分别为-10.24 mg / dL和0.13 +/- 0.03 EU / mL(P <0.001)。结果表明,益生菌或乳果糖均可显着降低高氨血症和高内毒素血症水平,减轻大鼠小叶中心坏死区以及肝脏的炎症反应,使BAEP潜伏期正常化,并降低MHE的发生率。然而,这两组之间没有观察到显着差异(P> 0.05)。结论:益生菌复合物Golden Bifid至少与乳果糖一样有效地预防和治疗MHE。益生菌疗法可能是一种安全,天然,耐受性良好的疗法,适合长期治疗MHE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号